Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,650 | -4,215 | -14,346 | -10,267 | -7,262 |
| Depreciation Amortization | 63 | 15 | 81 | 65 | 46 |
| Other Working Capital | 281 | 307 | 673 | 378 | 837 |
| Other Operating Activity | 4,242 | 758 | 4,534 | 3,369 | 2,369 |
| Operating Cash Flow | $-7,063 | $-3,135 | $-9,058 | $-6,455 | $-4,010 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -170 | -35 | -2 | -2 | -2 |
| Investing Cash Flow | $-170 | $-35 | $-2 | $-2 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -100 | -34 | -205 | -155 | -93 |
| Common Stock Issued | 4,786 | 58 | 16,722 | 16,722 | 2,948 |
| Financing Cash Flow | $4,686 | $24 | $16,517 | $16,567 | $2,855 |
| Beginning Cash Position | 10,378 | 10,378 | 2,921 | 2,921 | 2,921 |
| End Cash Position | 7,832 | 7,231 | 10,378 | 13,032 | 1,764 |
| Net Cash Flow | $-2,547 | $-3,147 | $7,457 | $10,111 | $-1,157 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,063 | -3,135 | -9,058 | -6,455 | -4,010 |
| Capital Expenditure | -170 | -35 | -2 | -2 | -2 |
| Free Cash Flow | -7,233 | -3,171 | -9,060 | -6,456 | -4,012 |